These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20844372)

  • 1. Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients.
    Calò LA; Davis PA
    J Hypertens; 2010 Oct; 28(10):2169-70; author reply 2171. PubMed ID: 20844372
    [No Abstract]   [Full Text] [Related]  

  • 2. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells?
    Tura O; Mills NL; Hadoke PW
    J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373
    [No Abstract]   [Full Text] [Related]  

  • 3. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
    Calò LA; Davis PA
    Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Caielli P; Rossi GP
    J Hypertens; 2012 Jul; 30(7):1406-13. PubMed ID: 22573121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
    Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
    Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
    Calò LA; Maiolino G
    J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
    Calò LA; Davis PA; Rossi GP
    J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HO-1 attenuates hypertension-induced inflammation/oxidative stress: support from Bartter's/Gitelman's patients.
    Calò LA; Fusaro M; Davis PA
    Am J Hypertens; 2010 Sep; 23(9):936; author reply 937. PubMed ID: 20733571
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
    Calò LA
    Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
    Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
    High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
    Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
    Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.
    Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC
    J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435
    [No Abstract]   [Full Text] [Related]  

  • 13. Bartter's/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling.
    Calò LA; Davis PA; Semplicini A
    Clin Nephrol; 2003 May; 59(5):393-4. PubMed ID: 12779105
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More.
    Ravarotto V; Bertoldi G; Stefanelli LF; Nalesso F; Calò LA
    Kidney Blood Press Res; 2022; 47(9):556-564. PubMed ID: 35858584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
    Calò LA; Davis PA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases.
    Favero M; Calò LA; Schiavon F; Punzi L
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
    Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
    Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
    Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
    Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
    J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.